Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE (SR) TABLETS safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE (SR) TABLETS.BUPROPION hydrochloride extended-release (SR) tablets for oral useInitial U.S. Approval: 1985
Medication labelWhy this: Advisory · dailymed-prescription
Bupropion hydrochloride extended-release (SR) tablets are indicated for the treatment of major depressive disorder (MDD), as defined by the Diagnostic and Statistical Manual (DSM). The efficacy of bupropion in the treatment of a major depressive episode was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult subjects with MDD [see Clinical Studies (14)]. The efficacy of bupropion hydrochloride extended-release (SR) tablets in maintaining an antidepressant response for up to 44 weeks following 8 weeks of acute treatment was demonstrated in a placebo-controlled trial [see Clinical Studies (14)].
- generic_name
- bupropion hydrochloride
- product_names
- Bupropion hydrochloride, bupropion hydrochloride
- ndc
- 43547-288, 43547-288-06, 43547-288-09, 43547-288-10, 43547-288-50, 43547-289, 43547-289-06, 43547-289-09, 43547-289-10, 43547-289-25, 43547-289-50, 43547-290, 43547-290-06, 43547-290-09, 43547-290-10, 43547-290-50
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en